These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 25204434)
21. Development of Thiochroman Dioxide Analogues of Benzothiadiazine Dioxides as New Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors. Etsè KS; Dorosz J; McLain Christensen K; Thomas JY; Botez Pop I; Goffin E; Colson T; Lestage P; Danober L; Pirotte B; Kastrup JS; Francotte P ACS Chem Neurosci; 2021 Jul; 12(14):2679-2692. PubMed ID: 34242002 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular activity of 1,2,4-benzothiadiazine-1,1-dioxide derivatives. Part 10(3): Dialkylamino-, pyrrolidyl- and morpholyl-alkyl-derivatives of 3-amino-1,2,4-benzothiadiazine-1,1-dioxide, 7- or 5,7-halogen substituted. Parenti C; Costantino L; Di Bella M; Raffa L; Baggio GG Pharmazie; 1988 Jan; 43(1):37-9. PubMed ID: 3375300 [TBL] [Abstract][Full Text] [Related]
23. New caged neurotransmitter analogs selective for glutamate receptor sub-types based on methoxynitroindoline and nitrophenylethoxycarbonyl caging groups. Palma-Cerda F; Auger C; Crawford DJ; Hodgson AC; Reynolds SJ; Cowell JK; Swift KA; Cais O; Vyklicky L; Corrie JE; Ogden D Neuropharmacology; 2012 Sep; 63(4):624-34. PubMed ID: 22609535 [TBL] [Abstract][Full Text] [Related]
24. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists. Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460 [TBL] [Abstract][Full Text] [Related]
25. Thermodynamic characterization of new positive allosteric modulators binding to the glutamate receptor A2 ligand-binding domain: combining experimental and computational methods unravels differences in driving forces. Nørholm AB; Francotte P; Goffin E; Botez I; Danober L; Lestage P; Pirotte B; Kastrup JS; Olsen L; Oostenbrink C J Chem Inf Model; 2014 Dec; 54(12):3404-16. PubMed ID: 25420075 [TBL] [Abstract][Full Text] [Related]
26. Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase. Zhang S; Chen X; Parveen S; Hussain S; Yang Y; Jing C; Zhu C ChemMedChem; 2013 Apr; 8(4):603-13. PubMed ID: 23136050 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of (4R)-alkyl glutamate analogues at the ionotropic glutamate receptors--focus on subtypes iGlu(5-7). Bunch L; Gefflaut T; Alaux S; Sagot E; Nielsen B; Pickering DS Eur J Pharmacol; 2009 May; 609(1-3):1-4. PubMed ID: 19285062 [TBL] [Abstract][Full Text] [Related]
28. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317 [TBL] [Abstract][Full Text] [Related]
29. 1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands. Tait A; Luppi A; Franchini S; Preziosi E; Parenti C; Buccioni M; Marucci G; Leonardi A; Poggesi E; Brasili L Bioorg Med Chem Lett; 2005 Feb; 15(4):1185-8. PubMed ID: 15686938 [TBL] [Abstract][Full Text] [Related]
30. New insights in the development of positive allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors belonging to 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides: Introduction of (mono/difluoro)methyl groups at the 2-position of the thiadiazine ring. Goffin E; Fraikin P; Abboud D; de Tullio P; Beaufour C; Botez I; Hanson J; Danober L; Francotte P; Pirotte B Eur J Med Chem; 2023 Mar; 250():115221. PubMed ID: 36863228 [TBL] [Abstract][Full Text] [Related]
31. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
32. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793 [TBL] [Abstract][Full Text] [Related]
33. Competitive AMPA receptor antagonists. Catarzi D; Colotta V; Varano F Med Res Rev; 2007 Mar; 27(2):239-78. PubMed ID: 16892196 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists. Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840 [TBL] [Abstract][Full Text] [Related]
35. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds. Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762 [TBL] [Abstract][Full Text] [Related]
36. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Armstrong N; Sun Y; Chen GQ; Gouaux E Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426 [TBL] [Abstract][Full Text] [Related]